Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Depreciation & Amortization (CF): 2013-2017

Historic Depreciation & Amortization (CF) for Tvardi Therapeutics (TVRD) over the last 5 years, with Dec 2017 value amounting to $125,000.

  • Tvardi Therapeutics' Depreciation & Amortization (CF) rose 5.04% to $125,000 in Q4 2017 from the same period last year, while for Dec 2017 it was $495,000, marking a year-over-year decrease of 66.21%. This contributed to the annual value of $192,000 for FY2024, which is 25.87% down from last year.
  • As of Q4 2017, Tvardi Therapeutics' Depreciation & Amortization (CF) stood at $125,000, which was down 0.00% from $125,000 recorded in Q3 2017.
  • In the past 5 years, Tvardi Therapeutics' Depreciation & Amortization (CF) ranged from a high of $730,000 in Q1 2016 and a low of $97,000 during Q3 2016.
  • Over the past 3 years, Tvardi Therapeutics' median Depreciation & Amortization (CF) value was $159,000 (recorded in 2015), while the average stood at $233,250.
  • In the last 5 years, Tvardi Therapeutics' Depreciation & Amortization (CF) soared by 278.24% in 2016 and then crashed by 83.29% in 2017.
  • Over the past 5 years, Tvardi Therapeutics' Depreciation & Amortization (CF) (Quarterly) stood at $197,000 in 2013, then fell by 2.03% to $193,000 in 2014, then surged by 34.20% to $259,000 in 2015, then slumped by 54.05% to $119,000 in 2016, then grew by 5.04% to $125,000 in 2017.
  • Its last three reported values are $125,000 in Q4 2017, $125,000 for Q3 2017, and $123,000 during Q2 2017.